Proton linear energy transfer and variable relative biological effectiveness for adolescent patients with Hodgkin lymphoma
Open Access
- 1 August 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in BJR|Open
- Vol. 5 (1)
Abstract
Objectives: Proton therapy has a theoretical dosimetric advantage due to the Bragg peak, but the linear energy transfer (LET), and therefore the relative biological effectiveness (RBE), increase at the end of range. For patients with Hodgkin lymphoma, the distal edge of beam is often located within or close to the heart, where elevated RBE would be of potential concern. The purpose of this study was to investigate the impact of RBE and the choice of beam arrangement for adolescent patients with mediastinal Hodgkin lymphoma. Methods: For three previously treated adolescent patients, proton plans with 1–3 fields were created to a prescribed dose of 19.8 Gy (RBE) in 11 fractions (Varian Eclipse v13.7), assuming an RBE of 1.1. Plans were recalculated using Monte-Carlo (Geant4 v10.3.3/Gate v8.1) to calculate dose-averaged LET. Variable RBE-weighted dose was calculated using the McNamara model, assuming an α/β ratio of 2 Gy for organs-at-risk. Results: Although the LET decreased as the number of fields increased, the difference in RBE-weighted dose (Δdose) to organs-at-risk did not consistently decrease. Δdose values varied by patient and organ and were mostly of the order of 0–3 Gy (RBE), with a worst-case of 4.75 Gy (RBE) in near-maximum dose to the left atrium for one plan. Conclusions: RBE-weighted doses to organs-at-risk are sensitive to the choice of RBE model, which is of particular concern for the heart. Advances in knowledge: There is a need to remain cautious when evaluating proton plans for Hodgkin lymphoma, especially when near-maximum doses to organs-at-risk are considered.Keywords
This publication has 57 references indexed in Scilit:
- Clinical consequences of relative biological effectiveness variations in proton radiotherapy of the prostate, brain and liverPhysics in Medicine & Biology, 2013
- Variations in Linear Energy Transfer Within Clinical Proton Therapy Fields and the Potential for Biological Treatment PlanningInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Radiation Dose–Volume Effects in the HeartInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic reviewHaematologica, 2009
- Proton Beam Therapy in Pediatric OncologyThe Cancer Journal, 2009
- The incorporation of the concept of minimum RBE (RBEmin) into the linear-quadratic model and the potential for improved radiobiological analysis of high-LET treatmentsInternational Journal of Radiation Biology, 2007
- Proton therapyPhysics in Medicine & Biology, 2006
- The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancerPhysics in Medicine & Biology, 2005
- Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factorsBlood, 2002
- A review of ratios for experimental tumors: Implications for clinical studies of altered fractionationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1985